Seattle Genetics (SGEN) shares are up 9% in pre-market hours today following the news that Merck will make a $1 billion equity investment …
Merck & Co. (MRK) has now started testing its experimental Covid-19 vaccine candidate V591 in healthy volunteers, according to a report from the …
The pharmaceutical industry is considered to be more resilient in difficult economic times compared to other industries. However, this time around, the coronavirus-led …
Merck & Co. announced on Monday that Japan’s regulator approved the drugmaker’s Keytruda therapy for the treatment of patients with advanced esophageal squamous …
Goldman Sachs on Monday upgraded pharma giant Merck & Co. to Buy from Hold, citing its strong pipeline and cancer drug Keytruda.
Merck (MRK) and Novocure (NVCR) have entered into a clinical trial collaboration agreement to develop Tumor Treating Fields together with Merck’s anti-PD-1 therapy …
Merck (MRK) and BioInvent International have announced the enrollment of the first patient in a Phase I/IIa clinical trial of BI-1206 in combination …
China has approved Merck’s (MRK) anti-PD-1 therapy, Keytruda, as monotherapy for the treatment of locally advanced or metastatic esophageal squamous cell carcinoma (ESCC) …
Merck (MRK) has announced that the U.S.
Five companies have now been picked by the Trump administration as the most likely candidates to produce a coronavirus vaccine, The New York …
